Related Experiment Video
Updated: Jul 9, 2025

12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.5K
Tumor-killing viruses score rare success in late-stage trial
Abstract:
Bladder cancer results suggest that after decades of failure, the viruses could finally reach their potential.
Insights
Viruses show promise in treating bladder cancer after years of research. This breakthrough could offer new therapeutic options for patients.
Area of Science:
- Oncology
- Virology
- Cancer Therapeutics
Background:
- Bladder cancer remains a significant health concern with limited treatment advancements.
- Viral therapies have been explored for cancer treatment for decades with limited success.
Related Concept Videos
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376

